Zimmer Biomet Holdings Inc (ZBH)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$108.18

Buy

$109.18

arrow-down$-0.51 (-0.47%)

Prices updated at 09 Nov 2024, 00:00 EST
| Prices minimum 15 mins delay
|
Prices in USD
Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris.
S&P 500
arrow-up0.38%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

0.240
Cash Dividend
30 Sep 2024
29 Aug 2024
30 Sep 2024
31 Oct 2024

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20240.7200-
20230.9600-
20220.9600-
20210.9600-
20200.9600-
20190.9600-
20180.9600-
20170.9600-
20160.96000.09
20150.8800-

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20240.905.67
20230.791.61
20220.75-
20210.76-
20200.62-
20190.64-
20180.93-
20170.80-
20160.93-
20150.86-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20240.7200
20230.9600
20220.9600
20210.9600
20200.9600
20190.9600
20180.9600
20170.9600
20160.9600
20150.8800

% of earnings paid to shareholders data table

YearPayout ratio (%)
202418.32
202342.48
202262.34
202124.43
2020-
2019-
201811.18
201730.00
201651.37
201588.00
Latest Financial Report as of 07 Nov 2024
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.